The FGFR1 gene helps cells respond to growth signals that guide early body development, including the brain, bones, and hormone systems. If this gene does not work properly, some people may have delayed or absent puberty, fertility problems, a reduced sense of smell, or differences in head, face, or limb development. The protein made by this gene helps your cells communicate during key stages of growth. Effects can vary a lot from one person to another, depending on the specific variant.
What is a gene?
A gene is a stretch of DNA that carries instructions cells can use to make molecules or regulate processes in the body. Some genes hold the instructions for producing proteins, the functional parts of cells. Others mainly help decide when, where, and how strongly specific processes take place. Together, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medications. To explore this subject in more detail, you can learn more in the LearnHub.
Overview
FGFR1Gene function
What if the gene works
The FGFR1 gene helps cells receive growth signals. It supports early development of the brain, face, and bones, and also helps with tissue repair and blood vessel growth.
Risk
What if the gene does not work
Variants in the FGFR1 gene often affect development, commonly causing delayed or absent puberty with or without smell loss. Milder to more severe variants can be linked to cleft lip or palate, skull bone fusion, or brain and limb differences.
Treatment
What does that mean for your treatment
No treatment or drug choice approach specific to pathogenic or loss-of-function variants in the FGFR1 gene is currently established. The FGFR1 gene is an active drug target in oncology, but current targeted therapies mainly apply to certain activating FGFR changes in cancer, not inherited loss-of-function variants.
Conditions associated with FGFR1
Gene function
What if the gene works
Your cells need steady messages to know when to grow, move, or settle into a specific job. Understanding what the FGFR1 gene does helps explain how cells receive growth signals during development and everyday tissue upkeep. This gene is especially important when the body is building tissues and keeping cell communication organized.
The FGFR1 gene helps cells detect growth signals from nearby tissues. Its protein sits at the cell surface and passes those messages inward so the cell can respond in an organized way.
Signals through the FGFR1 gene help guide when cells grow, divide, and stay active. This supports steady tissue building during development and routine tissue upkeep later in life.
Activity from the FGFR1 gene helps cells mature into the right type at the right time. This is part of how developing tissues form structures with the correct shape and role.
During early development, the FGFR1 gene helps coordinate where cells move and how groups of cells are arranged. This supports the formation of body structures in a controlled sequence.
What is a variant?
A genetic variant is a slight change in the DNA sequence within a gene. These changes are common and help account for normal human diversity, such as differences in appearance, metabolism, or how the body responds to environmental influences. Many variants have no noticeable effect and are simply part of natural genetic variation. In some cases, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the FGFR1 gene can change the protein’s shape, stability, or delivery to the cell surface, leading to weaker, mistimed, or sometimes excessive cell signaling. Milder variants may leave some signaling intact, while more severe variants can sharply reduce signaling or, less often, increase it too much. This range helps explain how FGFR1 gene variants affect cell signaling and why conditions linked to the FGFR1 gene can differ in when they appear and which features develop.
How variants are linked to conditions
Pathogenic variants in the FGFR1 gene are a well-established cause of congenital hypogonadotropic hypogonadism, and FGFR1 gene variants linked to Kallmann syndrome often come with delayed or absent puberty plus a reduced sense of smell. Other confirmed conditions linked to the FGFR1 gene include Hartsfield syndrome, osteoglophonic dysplasia, and some cases of Pfeiffer syndrome.
A variant is not necessarily a diagnosis
Variants in genes are a usual part of human biology and are widely found across the general population. Most do not directly affect health and simply reflect natural human diversity. For many genes, having a variant associated with a condition points to a possible link rather than a certain diagnosis, particularly when more than one gene and environmental influences are involved. In other cases, though, one well characterized variant in a particular gene may be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risks linked to the FGFR1 gene. In families with an FGFR1 change, the main factor is whether that change is present, while the effects can still vary from one person to another.
Inheritance of FGFR1 variants
The inheritance pattern for FGFR1-related conditions can differ depending on the specific condition and variant. Many well-known FGFR1 gene conditions are inherited in an autosomal dominant way, which means a parent carrying the variant has a 50% chance of passing it to each child, and some cases happen because of a new variant that was not inherited from either parent. More rarely, certain FGFR1 gene conditions follow autosomal recessive inheritance, which means a child inherits one variant copy from each parent.
What does my FGFR1 result mean for my family?
FGFR1 changes linked to known health conditions are often passed down in a dominant way, which means a parent, brother, sister, or child may also carry the same change. Because FGFR1 is tied to more than one condition, and not all follow the same family pattern, what it means for relatives depends on the exact result and the condition involved. In many families, close relatives may choose to talk with their care team about whether testing would be useful.
Genetic information
Genetic testing
How you find out about variants
Testing for FGFR1 variants usually uses a blood sample, saliva, or a cheek swab. A lab reads the DNA code in the FGFR1 gene, often as part of a broader test that checks many genes at once, to look for changes linked to inherited conditions. Results may show a pathogenic variant, a benign variant, or an unclear finding.
When should I consider getting a genetic test?
Genetic testing for the FGFR1 gene may be worth considering with delayed or absent puberty, a reduced sense of smell, infertility linked to low hormone signals, or a family history of these problems. It can also help explain some rare birth differences affecting the face, hands, or brain when an FGFR1-related condition is suspected.
A genetic result is only one part of your health story
Genetic test findings can provide useful insight, but how much they reveal varies by the condition and the specific type of variant. Many factors, including lifestyle, environment, age, and medical history, also shape how the body works over time. For some conditions, especially those influenced by many genes, genetic information adds context rather than certainty and is best understood alongside other parts of care. In other situations, a genetic result may offer a clear answer. In areas such as medication response, these results can also help make sense of individual experiences.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. A treatment that works well for one person may work less well for another, or may cause more side effects, because the body can absorb, break down, transport, or respond to a drug differently. These differences are common and can influence how strongly a medicine works or how sensitive someone is to it.
What is Pharmacogenetics?
Pharmacogenetics examines the ways genetic differences shape a person’s response to medicines. It focuses on relationships between genes and medications to explain why the same treatment can affect people differently. With many drugs, genes influence both how powerfully a medicine works and how the body handles it. This information can support treatment decisions that are better informed and more individualized. More on this topic is available in the LearnHub.
Drugs influenced by the FGFR1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in routine medication response, so general health or medication concerns are best discussed with your doctor. In cancer care, FGFR1 changes may sometimes be reviewed as part of tumor testing when doctors are considering targeted treatment options.
History
Research on the FGFR1 gene grew out of work on fibroblast growth factors in the 1970s and 1980s, when scientists were trying to understand how cells receive growth signals. Building on this early work, scientists cloned the FGFR1 gene in the late 1980s and identified it as one of the first receptors in this important signaling family. In the years that followed, changes involving the FGFR1 gene were linked to certain blood cancers through chromosome swaps, which helped establish its place in cancer genetics. Researchers later connected variants in the FGFR1 gene to inherited conditions affecting puberty, sense of smell, and early development. Over time, descriptions became more precise. Today, the FGFR1 gene is recognized as part of a broader chapter in genetics that connected growth signals, development, and cancer research.